Table 1. Baseline characteristics of individuals.
| Non-Progression (n = 214) | Progression (n = 40) |
Total (n = 254) |
p-value | |
|---|---|---|---|---|
| Sex (male) | 139 | 20 | 159 | 0.07 |
| Age (years) | 58.22 ± 14.33 | 62.90 ± 16.21 | 58.96 ± 14.70 | 0.06 |
| BMI (Kg/m2) | 25.12 ± 3.34 | 25.68 ± 4.46 | 25.21 ± 3.53 | 0.35 |
| Waistline (cm) | 88.42 ± 8.70 | 90.03 ± 9.85 | 88.67 ± 8.89 | 0.30 |
| Hipline (cm) | 94.01 ± 7.52 | 96.48 ± 9.14 | 94.40 ± 7.83 | 0.06 |
| Systolic pressure (mmHg) | 130.20 ± 14.91 | 138.50 ± 17.50 | 131.50 ± 15.60 | <0.01 |
| Diastolic pressure (mmHg) | 78.73 ± 9.74 | 82.28 ± 10.86 | 79.29 ± 9.98 | 0.04 |
| Heart rate (beat/min) | 77.77 ± 7.71 | 75.65 ± 8.62 | 77.44 ± 7.87 | 0.12 |
| Comorbidities | ||||
| Hypertension | 114 | 31 | 145 | <0.01 |
| Smoking | 53 | 9 | 62 | 0.80 |
| Drinking | 25 | 6 | 31 | 0.56 |
| Coronary heart disease | 43 | 7 | 50 | 0.71 |
| Diabetic retinopathy | 55 | 14 | 69 | 0.23 |
| Use of RAAS inhibitor | 102 | 25 | 127 | 0.09 |
Note:
RAAS: Renin-Angiotensin-Aldosterone system.